Acetyldigitoxin
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
[(2R,3R,4S,6S)-3-Hydroxy-6-[(2R,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[ [(5R,8R,9S,10S,13R,14S,17R')-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate | |
| Identifiers | |
| CAS Number |
1111-39-3 |
| ATC code | C01AA01 (WHO) |
| PubChem | CID 68949 |
| DrugBank |
DB00511 |
| ChemSpider |
4447572 |
| UNII |
0ZV4Q4L2FU |
| KEGG |
D06881 |
| ChEBI |
CHEBI:53773 |
| ChEMBL |
CHEMBL1200634 |
| Chemical data | |
| Formula | C43H66O14 |
| Molar mass | 806.976 g/mol |
| |
| |
| | |
Acetyldigitoxin is a cardiac glycoside. It is an acetyl derivative of digitoxin.
| ||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
